PHYSIOLOGICAL DISPOSITION OF HMG-COA-REDUCTASE INHIBITORS

[1] DISCOVERY, BIOCHEMISTRY AND BIOLOGY OF LOVASTATIN [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1988, 62 (15) : J10 - J15

[2] ALBERTS AW, 1986, 9TH INT S DRUGS AFF, P8

[3] Arai M, 1988, SANKYO KENKYUSHO NEM, V40, P1

[4] A RECEPTOR-MEDIATED PATHWAY FOR CHOLESTEROL HOMEOSTASIS [J]. SCIENCE, 1986, 232 (4746) : 34 - 47

[5] CLARK R W, 1989, FASEB Journal, V3, pA953

[6] DUGGAN D, UNPUB

[7] DUGGAN DE, 1989, DRUG METAB DISPOS, V17, P166

[8] DUGGAN DE, 1989, INT ATHEROSCLEROSIS

[9] EAST C, 1988, NEW ENGL J MED, V318, P47

[10] CHEMISTRY, BIOCHEMISTRY, AND PHARMACOLOGY OF HMG-COA REDUCTASE INHIBITORS [J]. KLINISCHE WOCHENSCHRIFT, 1988, 66 (10): : 421 - 427

[1] DISCOVERY, BIOCHEMISTRY AND BIOLOGY OF LOVASTATIN [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1988, 62 (15) : J10 - J15

[2] ALBERTS AW, 1986, 9TH INT S DRUGS AFF, P8

[3] Arai M, 1988, SANKYO KENKYUSHO NEM, V40, P1

[4] A RECEPTOR-MEDIATED PATHWAY FOR CHOLESTEROL HOMEOSTASIS [J]. SCIENCE, 1986, 232 (4746) : 34 - 47

[5] CLARK R W, 1989, FASEB Journal, V3, pA953

[6] DUGGAN D, UNPUB

[7] DUGGAN DE, 1989, DRUG METAB DISPOS, V17, P166

[8] DUGGAN DE, 1989, INT ATHEROSCLEROSIS

[9] EAST C, 1988, NEW ENGL J MED, V318, P47

[10] CHEMISTRY, BIOCHEMISTRY, AND PHARMACOLOGY OF HMG-COA REDUCTASE INHIBITORS [J]. KLINISCHE WOCHENSCHRIFT, 1988, 66 (10): : 421 - 427